Evoke Pharma, Inc. Gains 23.29%
Fri, Mar 10, 2023 at 07:07 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) soared at $3.6, a gain of 23.3%. On Fri, Mar 10, 2023, EVOK:NASDAQ touched a New 2-Week High of $3.6. The stock got featured on our News Catalysts scanner on Tue, Feb 21, 2023 at 08:45 AM in the 'MISCELLANEOUS' category. From Fri, Feb 24, 2023, the stock recorded 70.00% Up Days and 45.45% Green Days
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 54.2%
- Cazoo Group Ltd Class A (CZOO:NYSE), 32.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 30.1%
- SportsMap Tech Acquisition Corp. (SMAP:NASDAQ), 29.83%
- Boxed Inc. (BOXD:NYSE), 26.89%
- Cingulate Inc. (CING:NASDAQ), 25%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 23.29%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 22.96%
- Solo Brands Inc. Class A (DTC:NYSE), 21.19%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 20.93%